Literature DB >> 3567011

Inter-subject and ethnic differences in paracetamol metabolism.

J A Critchley, G R Nimmo, C A Gregson, N M Woolhouse, L F Prescott.   

Abstract

The 24 h urinary excretion of paracetamol and its metabolites following a single oral dose of 1.5 g was compared in 111 Caucasians (Scotland), 67 West Africans (Ghana) and 20 East Africans (Kenya). The fractional recovery of the mercapturic acid and cysteine conjugates of paracetamol was 9.3% in the Caucasians compared with only 5.2% and 4.4% in the Ghanaians and Kenyans respectively (P = less than 0.0005). This probably indicates markedly reduced metabolic activation of paracetamol in the Africans. There were no ethnic differences in the sulphate conjugation of paracetamol, but the mean fractional recovery of the glucuronide conjugate in Caucasians (54%) was significantly less than in the Africans (58%). The sulphate conjugation of paracetamol was increased and glucuronide conjugation reduced in Caucasian females compared with males. A similar trend was seen in the Ghanaians but there were no other significant sex differences. The range of intersubject variation in the metabolic activation of paracetamol was sixty fold compared with only a three fold variation in glucuronide and sulphate conjugation. This has important implications for susceptibility to paracetamol hepatotoxicity following overdosage especially in a small subgroup showing extensive metabolic activation. These ethnic differences in paracetamol metabolism may be related to genetic or environmental factors including differences in diet and protein intake.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3567011      PMCID: PMC1401198          DOI: 10.1111/j.1365-2125.1986.tb02953.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  Paracetamol metabolism following overdosage: application of high performance liquid chromatography.

Authors:  D Howie; P I Adriaenssens; L F Prescott
Journal:  J Pharm Pharmacol       Date:  1977-04       Impact factor: 3.765

2.  The effect of diet on the toxicity of paracetamol and the safety of paracetamol-methionine mixtures.

Authors:  A E McLean; P A Day
Journal:  Biochem Pharmacol       Date:  1975-01-01       Impact factor: 5.858

3.  Progress in hepatology. Metabolic activation of drugs to toxic substances.

Authors:  J R Mitchell; D J Jollows
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

4.  Effect of protein-free diet on UDP-glucuronyltransferase and sulphotransferase activities in rat liver.

Authors:  B G Woodcock; G C Wood
Journal:  Biochem Pharmacol       Date:  1971-10       Impact factor: 5.858

5.  Inter-ethnic and inter-phenotype differences among Ghanaians and Caucasians in the metabolic hydroxylation of phenytoin [proceedings].

Authors:  B Andoh; J R Idle; T P Sloan; R L Smith; N Woolhouse
Journal:  Br J Clin Pharmacol       Date:  1980-03       Impact factor: 4.335

6.  Paracetamol metabolism in African villagers.

Authors:  D K Sommers; D A van Staden; J Moncrieff; H S Schoeman
Journal:  Hum Toxicol       Date:  1985-07

7.  Debrisoquin hydroxylation polymorphism among Ghanaians and Caucasians.

Authors:  N M Woolhouse; B Andoh; A Mahgoub; T P Sloan; J R Idle; R L Smith
Journal:  Clin Pharmacol Ther       Date:  1979-11       Impact factor: 6.875

8.  A population and familial study of the defective alicyclic hydroxylation of debrisoquine among Egyptians.

Authors:  A Mahgoub; J R Idle; R L Smith
Journal:  Xenobiotica       Date:  1979-01       Impact factor: 1.908

Review 9.  Kinetics and metabolism of paracetamol and phenacetin.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

10.  Environmental factors affecting paracetamol metabolism in London factory and office workers.

Authors:  J C Mucklow; H S Fraser; C J Bulpitt; C Kahn; G Mould; C T Dollery
Journal:  Br J Clin Pharmacol       Date:  1980-07       Impact factor: 4.335

View more
  46 in total

1.  Metabolism of paracetamol and phenacetin in relation to debrisoquine oxidation phenotype.

Authors:  M E Veronese; S McLean
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Effects of human SULT1A3/SULT1A4 genetic polymorphisms on the sulfation of acetaminophen and opioid drugs by the cytosolic sulfotransferase SULT1A3.

Authors:  Ahsan F Bairam; Mohammed I Rasool; Fatemah A Alherz; Maryam S Abunnaja; Amal A El Daibani; Katsuhisa Kurogi; Ming-Cheh Liu
Journal:  Arch Biochem Biophys       Date:  2018-04-26       Impact factor: 4.013

Review 3.  Deaths from low dose paracetamol poisoning.

Authors:  S Bridger; K Henderson; E Glucksman; A J Ellis; J A Henry; R Williams
Journal:  BMJ       Date:  1998-06-06

4.  Impaired absorption of paracetamol in vegetarians.

Authors:  L F Prescott; K Yoovathaworn; K Makarananda; R Saivises; K Sriwatanakul
Journal:  Br J Clin Pharmacol       Date:  1993-09       Impact factor: 4.335

5.  PharmGKB summary: pathways of acetaminophen metabolism at the therapeutic versus toxic doses.

Authors:  Liudmila L Mazaleuskaya; Katrin Sangkuhl; Caroline F Thorn; Garret A FitzGerald; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2015-08       Impact factor: 2.089

6.  Physiologically based modeling of the pharmacokinetics of acetaminophen and its major metabolites in humans using a Bayesian population approach.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-01-31       Impact factor: 2.441

7.  Gastric emptying following brain injury: effects of choice of sedation and intracranial pressure.

Authors:  C J McArthur; T Gin; I M McLaren; J A Critchley; T E Oh
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

8.  Characterizing the Effects of Race/Ethnicity on Acetaminophen Pharmacokinetics Using Physiologically Based Pharmacokinetic Modeling.

Authors:  Todd J Zurlinden; Brad Reisfeld
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-02       Impact factor: 2.441

9.  Abnormal serum transaminases following therapeutic doses of acetaminophen in the absence of known risk factors.

Authors:  D Kwan; W R Bartle; S E Walker
Journal:  Dig Dis Sci       Date:  1995-09       Impact factor: 3.199

Review 10.  Paracetamol poisoning in children and hepatotoxicity.

Authors:  A Penna; N Buchanan
Journal:  Br J Clin Pharmacol       Date:  1991-08       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.